ClinConnect ClinConnect Logo
Search / Trial NCT03131752

Early Pulmonary Rehabilitation in Exacerbated COPD Patients

Launched by UNIVERSIDADE FEDERAL DE SAO CARLOS · Apr 24, 2017

Trial Information

Current as of June 16, 2025

Unknown status

Keywords

Chronic Obstructive Pulmonary Disease Muscle Strength Physical Activity

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged 40 years or more, of both genders, who are in a an exacerbation of the disease according to Global Initiative for Chronic Obstructive Lung Disease (GOLD,2015) refered by the doctors, hospitalized or not in exacerbation treatment .All patients should be in spontaneous breathing at the time of assessment, in oxygen use or not and in conditions to understand the proposed evaluations; Patients who use non-invasive ventilation will also be included as long as it does not interfere with the protocols; All should agree to participate in the research in a free and informed manner. Patients who are referred to the Intensive Care Unit (ICU) may be included 24 hours after discharge from the ICU.
  • Exclusion Criteria:
  • Patients who present with orthopedic limitations, other pulmonary diseases, rheumatological, cardiovascular or neurological disorders that not allow the assessment. Patients whit drug os alcohol dependence, patients undergoing invasive mechanical ventilation, hemodynamic instability, the presence of unstable angina, will be excluded. In addition, patients with cognitive deficits that impair comprehension of the assessments will be excluded.

About Universidade Federal De Sao Carlos

The Universidade Federal de São Carlos (UFSCar) is a leading Brazilian institution dedicated to advancing research and education in the fields of science, technology, and health. With a strong emphasis on innovation and interdisciplinary collaboration, UFSCar fosters a vibrant academic environment that supports clinical trials aimed at addressing pressing health challenges. The university's commitment to high standards of ethical research and community engagement ensures that its clinical trials contribute valuable insights to the scientific community while promoting the well-being of diverse populations. Through its robust infrastructure and experienced research teams, UFSCar plays a pivotal role in advancing medical knowledge and improving patient care.

Locations

Sao Carlos, São Paulo, Brazil

Patients applied

0 patients applied

Trial Officials

Valeria Di Lorenzo, PhD

Study Director

Universidade Federal de Sao Carlos

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials